Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Post by Stinzoon May 24, 2019 2:07am
98 Views
Post# 29770124

My 2 cents

My 2 cents-Since the completion of the new plant, the stock has averaged a .4 stock price in the last 6 months or so. -The company reported record sales in the last 2 quarters, stock price has not moved on such news. -The company has increased online marketing presence in the last few months with interviews, no volume change. -Company continues to receive patents/certification, no volume change. -Company continues to mention its looking for deals and interested parties, still waiting. -I am no biotech scientific expert but I keep doubting the value of this PGX technology. The market also seems to value this at 0. -In the next 2-3 weeks, there should be about 3 new press releases. I hope we can see some stock volume action as this company, even though it probably looks very positive from an insiders eye, it is looking very gloomy from the outside. GLTA
Bullboard Posts